The global Molecular Pharming market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.

• To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
• Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
• Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.

Segmentation by Type:

• Gene Gun
• Agroinfiltration
• Electroporation
• Agrobacterium-Mediated Gene Transfer

Segmentation by Application:

• Recombinant Antibodies
• Hormones, Vaccines
• Industrial Enzymes
• Proteins & Protein-Based Materials
• Technical Reagents
• Nutritional Products

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company's Coverage with Companies listed:

• Medicago Inc
• Meristem Therapeutics S.A. (Ventria Bioscience)
• Miruku
• Moolec Science Limited
• mozza
• Nobell Foods
• Agrenvec S.L
• Bright Biotech
• Core Biogenesis
• Diamante SRL
• Leaf Systems International Limited
• ORF Genetics
• Pfizer, Inc.
• ProdiGene Inc
• Protalix Biotherapeutics, Inc
• Tiamat Sciences

Key Questions Addressed in this Report